Skip to content

Author

S. Arıkan-Akdağlı

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Trial Endpoints for Candidemia and Invasive Candidiasis: Consensus Recommendations by the Mycoses Study Group Education & Research Consortium and European Confederation of Medical Mycology.

Invasive candidiasis (IC) remains the most common invasive mycosis world-wide, responsible for a wide range of infections that can range from superficial mucosal infections to life-threatening systemic diseases. Clinical trials of antifungal agents for IC are pivotal to its management. Therapeutic responses in these tr...

J. Vazquez, S. C. Chen, S. Shoham et al. · 0 citations
Review Open access Nov 2026

Posaconazole in Clinical Practice: A Narrative Review of Current Evidence and Expert Recommendations

Posaconazole is a broad-spectrum antifungal agent used to manage invasive fungal infections (IFIs), particularly in high-risk immunocompromised patients. It is active against a range of fungal pathogens, including Candida spp., Aspergillus spp., and Mucorales. The introduction of delayed-release tablets and intravenous...

H. Akalın, S. Arıkan-Akdağlı, M. Ar et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.